Trajectories of function and biomarkers with age: the CHS All Stars Study
- PMID: 27272182
- PMCID: PMC5841627
- DOI: 10.1093/ije/dyw092
Trajectories of function and biomarkers with age: the CHS All Stars Study
Abstract
Background: Multimorbidity is a major driver of physical and cognitive impairment, but rates of decline are also related to ageing. We sought to determine trajectories of decline in a large cohort by disease status, and examined their correspondence with biomarkers of ageing processes including growth hormone, sex steroid, inflammation, visceral adiposity and kidney function pathways.
Methods: We have followed the 5888 participants in the Cardiovascular Health Study (CHS) for healthy ageing and longevity since 1989-90. Gait speed, grip strength, modified mini-mental status examination (3MSE) and the digit symbol substitution test (DSST) were assessed annually to 1998-99 and again in 2005-06. Insulin-like growth hormone (IGF-1), dehydroepiandrosterone sulphate (DHEAS), interleukin-6 (IL-6), adiponectin and cystatin-C were assessed 3-5 times from stored samples. Health status was updated annually and dichotomized as healthy vs not healthy. Trajectories for each function measure and biomarker were estimated using generalized estimating equations as a function of age and health status using standardized values.
Results: Trajectories of functional decline showed strong age acceleration late in life in healthy older men and women as well as in chronically ill older adults. Adiponectin, IL-6 and cystatin-C tracked with functional decline in all domains; cystatin-C was consistently associated with functional declines independent of other biomarkers. DHEAS was independently associated with grip strength and IL-6 with grip strength and gait speed trajectories.
Conclusions: Functional decline in late life appears to mark a fundamental ageing process in that it occurred and was accelerated in late life regardless of health status. Cystatin C was most consistently associated with these functional declines.
Keywords: Ageing; biomarkers; cognitive function; disability; gait speed; grip strength.
© The Author 2016; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association.
Figures
References
-
- Kaplan RC, McGinn AP, Pollak MN. et al. Total insulinlike growth factor 1 and insulinlike growth factor binding protein levels, functional status, and mortality in older adults. J Am Geriatr Soc 2008;56:652–60. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 HL080295/HL/NHLBI NIH HHS/United States
- HHSN268201200036C/HL/NHLBI NIH HHS/United States
- K01 AG039387/AG/NIA NIH HHS/United States
- N01HC85082/HL/NHLBI NIH HHS/United States
- N01HC55222/HL/NHLBI NIH HHS/United States
- N01HC85086/HL/NHLBI NIH HHS/United States
- R01 HL080295/HL/NHLBI NIH HHS/United States
- HHSN268200800007C/HL/NHLBI NIH HHS/United States
- N01HC85080/HL/NHLBI NIH HHS/United States
- P30 AG024827/AG/NIA NIH HHS/United States
- N01HC85079/HL/NHLBI NIH HHS/United States
- N01HC85083/HL/NHLBI NIH HHS/United States
- N01HC85081/HL/NHLBI NIH HHS/United States
- R01 AG023629/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
